Tributes paid following death of listed pharma company’s CFO

4D pharma, a Leeds-based pharmaceutical company leading the development of live biotherapeutic products, has confirmed this afternoon that John Beck, the firm’s chief financial officer, has died.

Duncan Peyton, chief executive officer of the business, said: “We are deeply saddened by John’s passing. The entire 4D pharma community mourns this loss and, on behalf of our Board of Directors and employees, we extend our sincerest condolences to his family.

“John’s 30 years of experience in the financial and biopharmaceutical industries were invaluable to us in his role as chief financial officer, and his vision for the future of 4D pharma was already well on its way to being realised.

“We grieve this loss and will carry his legacy forward in this next chapter of 4D pharma continued growth and progress.”

4D pharma adds it will continue to be actively led by its current management team and Board of Directors and succession planning is underway.